HomeASBP • NASDAQ
add
Aspire Biopharma Holdings Inc
Previous close
$0.59
Day range
$0.59 - $0.62
Year range
$0.40 - $15.80
Market cap
30.31M USD
Avg Volume
850.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 242.62K | 270.21% |
Net income | -243.63K | -271.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.42% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.54K | — |
Total assets | 184.04K | — |
Total liabilities | 985.63K | — |
Total equity | -801.59K | — |
Shares outstanding | 443.32M | — |
Price to book | ∞ | — |
Return on assets | -23.14% | — |
Return on capital | -129.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -243.63K | -271.75% |
Cash from operations | -533.80K | -76.58% |
Cash from investing | 38.26K | 0.00% |
Cash from financing | 492.48K | 83.20% |
Net change in cash | -3.06K | -164.08% |
Free cash flow | -437.23K | — |
About
Founded
2021
Website
